Related Experiment Video
Updated: Feb 2, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Ventricular Arterial Coupling: A Novel Echocardiographic Risk Factor for Disease Progression in Pediatric Dilated
Christine A Capone1, Jacqueline M Lamour2, Josemiguel Lorenzo2
1Division of Pediatric Cardiology, Department of Pediatrics, The Children's Hospital at Montefiore, Albert Einstein College of Medicine, 3415 Bainbridge Avenue, R1, 10467, Bronx, NY, USA. christine.capone@gmail.com.
Insights
A higher ventricular arterial (VA) coupling ratio is linked to worse outcomes in children with dilated cardiomyopathy (DCM). This non-invasive measure may help predict heart failure progression and guide treatment in pediatric DCM patients.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Cardiovascular Physiology
Background:
- Ventricular arterial (VA) coupling is a known predictor of outcomes in adult heart failure (HF).
- Limited data exist on the association of VA coupling with prognosis in pediatric dilated cardiomyopathy (DCM).
Purpose of the Study:
- To investigate the relationship between the VA coupling ratio and adverse outcomes in pediatric DCM patients.
- To determine if VA coupling can predict the need for mechanical circulatory support, transplant, or death in children with DCM.
Main Methods:
- A case-control study involving 48 pediatric DCM patients and 97 age-gender matched controls.
- Non-invasive measurement of VA coupling ratio, arterial elastance, and left ventricular (LV) elastance.
- Multivariate analysis, including CART analysis, to identify predictors of outcome.
Main Results:
- DCM patients exhibited higher arterial elastance, lower LV elastance, and a significantly higher VA coupling ratio compared to controls.
- Patients experiencing adverse outcomes (mechanical support, transplant, or death) had higher NYHA class, lower LV elastance, higher arterial elastance, and a markedly elevated VA coupling ratio.
- VA coupling ratio was identified as the sole and primary discriminator of poor outcome in multivariate CART analysis.
Conclusions:
- An elevated VA coupling ratio is significantly associated with worse outcomes in pediatric DCM.
- VA coupling shows promise as a bedside tool for assessing pediatric DCM severity and guiding therapeutic strategies.
- Further research into VA coupling may elucidate mechanisms of pediatric HF and identify novel treatment targets.
Abstract:
In adult heart failure (HF) patients, a higher ventricular arterial (VA) coupling ratio measured non-invasively is associated with worse HF prognosis and response to treatment. There are no data regarding the relationship of VA coupling to outcome in pediatric dilated cardiomyopathy (DCM) patients. We investigated the association of VA coupling ratio with worse outcome (mechanical circulatory support, transplant, or death) in 48 children with DCM and 97 age-gender matched controls. Mean age at presentation was 9 ± 7 years; DCM patients had a higher arterial elastance (3.8 ± 1.7 vs 2.7 ± 0.7 respectively p = 0.001), a lower LV elastance (1.1 ± 0.65 vs 4.5 ± 1.4, respectively p = 0.001) and higher VA coupling ratio (5.0 ± 3.9 vs 0.34 ± 0.14, respectively p = 0.001). Outcome events occurred in 27/48 (56%) patients. Patients with an outcome event had a higher NYHA class (p = 0.001), lower LV elastance (0.8 ± 0.47 vs 1.6 ± 0.57, respectively p = 0.001), higher arterial elastance (4.5 ± 1.8 vs 2.9 ± 1.1, respectively p = 0.002), and a higher VA coupling ratio (7.1 ± 3.8 vs 2.2 ± 1.5, respectively p = 0.001) compared to those without. In a multivariate CART analysis, VA coupling was the top and only discriminator of poor outcome. In conclusion, a higher VA coupling ratio is associated with worse outcome in pediatric patients with DCM. VA coupling is promising as a bedside analysis tool that may provide insight into the mechanisms of HF in pediatric DCM and identify potential targets for therapy.
More Related Videos
07:55Echocardiographic Characterization of Left Ventricular Structure, Function, and Coronary Flow in Neonate Mice
Published on: April 7, 2022
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Coronary Artery Disease I: Introduction
Peripheral Artery Disease I: Introduction